Related Experiment Video
Updated: Dec 3, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The Role of Long Non-coding RNAs in Cancer Metabolism: A Concise Review
Soudeh Ghafouri-Fard1, Hamed Shoorei2, Mohammad Taheri3
1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
Dysregulation of metabolic pathways in cancer cells is regarded as a hallmark of cancer. Identification of these abnormalities in cancer cells dates back to more than six decades, far before discovery of oncogenes and tumor suppressor genes. Based on the importance of these pathways, several researchers have aimed at modulation of these functions to intervene with the pathogenic course of cancer. Numerous genes have been shown to participate in the regulation of metabolic pathways, thus aberrant expression of these genes can be involved in the pathogenesis of cancer. The recent decade has experienced a significant attention toward the role of long non-coding RNAs (lncRNAs) in the biological functions. These transcripts regulate expression of genes at several levels, therefore influencing the activity of cancer-related pathways. Among the most affected pathways are those modulating glucose homeostasis, as well as amino acid and lipid metabolism. Moreover, critical roles of lncRNAs in regulation of mitochondrial function potentiate these transcripts as novel targets for cancer treatment. In the current review, we summarize the most recent literature regarding the role of lncRNAs in the cancer metabolism and their significance in the design of therapeutic modalities.
Insights
Long non-coding RNAs (lncRNAs) significantly impact cancer metabolism by regulating key pathways like glucose, amino acid, and lipid homeostasis. These lncRNAs offer promising new targets for developing innovative cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Metabolic pathway dysregulation is a cancer hallmark, recognized over 60 years ago.
- Gene expression alterations, including those in metabolic pathways, contribute to cancer pathogenesis.
- Long non-coding RNAs (lncRNAs) have emerged as critical regulators of biological functions in the last decade.
Purpose of the Study:
- To review the recent literature on the role of lncRNAs in cancer metabolism.
- To highlight the significance of lncRNAs in developing novel cancer therapeutic strategies.
Main Methods:
- Comprehensive literature review of studies investigating lncRNAs and cancer metabolism.
- Analysis of lncRNA regulatory mechanisms in key metabolic pathways.
- Evaluation of lncRNAs' role in mitochondrial function and potential as therapeutic targets.
Main Results:
- lncRNAs regulate gene expression at multiple levels, influencing cancer-related pathways.
- lncRNAs are implicated in the dysregulation of glucose, amino acid, and lipid metabolism in cancer.
- lncRNAs play critical roles in regulating mitochondrial function, presenting them as potential therapeutic targets.
Conclusions:
- lncRNAs are key players in cancer metabolism, affecting fundamental processes like energy homeostasis.
- Targeting lncRNAs involved in cancer metabolism represents a promising avenue for novel therapeutic interventions.
- Further research into lncRNA functions can accelerate the design of effective cancer treatments.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
